Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Leon Alexander Mclaren Berge, Bettina Kulle Andreassen, Jo Steinson Stenehjem, Trond Heir, Øystein Karlstad, Asta Juzeniene, Reza Ghiasvand, Inger Kristin Larsen, Adele C Green, Marit Bragelien Veierød & Trude Eid Robsahm. (2020) Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study. Clinical Epidemiology 12, pages 1389-1401.
Read now
Read now
Nikolai Dyrberg Loft, Sofie Vaengebjerg & Lone Skov. (2020) Cancer risk in patients with psoriasis: should we be paying more attention?. Expert Review of Clinical Immunology 16:5, pages 479-492.
Read now
Read now
Steve R. Feldman, Frank A. Lacy & William W. Huang. (2018) The safety of treatments used in pyoderma gangrenosum. Expert Opinion on Drug Safety 17:1, pages 55-61.
Read now
Read now
Articles from other publishers (37)
Mahadi Hasan, Anowara Khatun & Kentaro Kogure. (2023) Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis. Pharmaceutics 15:12, pages 2678.
Crossref
Crossref
Daphne G. Eckembrecher, Francelia J. Eckembrecher, Isabella Camacho, Hemali Shah, Yogi Dave, Shrey Patel & Keyvan Nouri. (2023) A review of heart transplant immunosuppressants and nonmelanoma skin cancer. Archives of Dermatological Research.
Crossref
Crossref
Margaret Ann Kreher, Mary Margaret B. Noland, Sailesh Konda, Maria I. Longo & Rodrigo Valdes-Rodriguez. (2023) Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids. Journal of the American Academy of Dermatology 88:3, pages 521-530.
Crossref
Crossref
Detlef Becker. 2023. Berufsdermatologie. Berufsdermatologie
303
321
.
Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic, Adil Daud, Alain Algazi, Klemens Rappersberger & Susana Ortiz-Urda. (2022) Melanoma risk during immunomodulating treatment. Melanoma Research 32:6, pages 411-418.
Crossref
Crossref
Marc Schmalzing. (2022) Management von entzündlich rheumatischen Erkrankungen während und nach MalignomenManagement of inflammatory rheumatic diseases during and after malignancies. Zeitschrift für Rheumatologie 81:9, pages 766-777.
Crossref
Crossref
María Paz Rollan, Raúl Cabrera & Robert A. Schwartz. (2022) Current knowledge of immunosuppression as a risk factor for skin cancer development. Critical Reviews in Oncology/Hematology 177, pages 103754.
Crossref
Crossref
Amy Semaka & Thomas G. Salopek. (2021) Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature. Journal of Cutaneous Medicine and Surgery 26:1, pages 87-92.
Crossref
Crossref
Mohamed M. Ibrahim & Tarek Alhamad. 2022. Complications in Kidney Transplantation. Complications in Kidney Transplantation
225
230
.
Laura Gheucă-Solovăstru, Dan Vâţă, Alina Ioana Halip, Adriana Patraşcu, Andreea Cozma & Elena Porumb-Andrese. (2021) Psoriasis—A Cancer Risk Factor?. Applied Sciences 11:18, pages 8366.
Crossref
Crossref
Johannes Wohlrab, Ulrich Mrowietz, Stephan Weidinger, Thomas Werfel & Andreas Wollenberg. (2020) Handlungsempfehlung zur Therapieumstellung von Immunsuppressiva auf Dupilumab bei Patienten mit atopischer DermatitisRecommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis. Der Hautarzt 72:4, pages 321-327.
Crossref
Crossref
Sahil Sekhon, Tina Bhutani & John Y.M. Koo. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
187
198.e3
.
Kevin K. Wu & April W. Armstrong. 2021. Dermato-Oncology Study Guide. Dermato-Oncology Study Guide
149
190
.
Marc Schmalzing. (2020) Rheumatologische medikamentöse Therapie bei Malignomanamnese. Aktuelle Rheumatologie 45:06, pages 523-530.
Crossref
Crossref
Grażyna Janikowska, Ewa Kurzeja, Marcin Janikowski, Barbara Strzałka-Mrozik, Alina Pyka-Pająk & Tomasz Janikowski. (2020) The Effect of Cyclosporine A on Dermal Fibroblast Cell - Transcriptomic Analysis of Inflammatory Response Pathway. Current Pharmaceutical Biotechnology 21:12, pages 1213-1223.
Crossref
Crossref
Marius Rademaker, Karen Agnew, Megan Andrews, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Diana M. Rubel, Colin Somerville, John Sullivan & Li‐Chuen Wong. (2019) Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative. Australasian Journal of Dermatology 61:1, pages 9-22.
Crossref
Crossref
Aleksandar Poleksic & Lei Xie. (2019) Database of adverse events associated with drugs and drug combinations. Scientific Reports 9:1.
Crossref
Crossref
Lauren D. Crow, Katherine A. Kaizer-Salk, Hailey M. Juszczak & Sarah T. Arron. (2019) Medications Associated with Increased Risk of Keratinocyte Carcinoma. Dermatologic Clinics 37:3, pages 297-305.
Crossref
Crossref
J. Berth‐Jones, L.S. Exton, E. Ladoyanni, M.F. Mohd Mustapa, V.M. Tebbs, P.D. Yesudian, N.J. Levell, P.M. McHenry, T.A. Leslie, S. Wakelin, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, N. Chiang, F.S. Worsnop, A. Salim, D. Buckley, G. Petrof, N. Callachand, T. Flavell & A.A. Salad. (2019) British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. British Journal of Dermatology 180:6, pages 1312-1338.
Crossref
Crossref
Marius Rademaker, Karen Agnew, Nicholas Anagnostou, Megan Andrews, Katherine Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Gillian Marshman, Diana Rubel, John Sullivan & Li‐Chuen Wong. (2018) Psoriasis and infection. A clinical practice narrative. Australasian Journal of Dermatology 60:2, pages 91-98.
Crossref
Crossref
Marius Rademaker, Diana M Rubel, Karen Agnew, Megan Andrews, Katherine Sarah Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Michelle SY Goh, Monisha Gupta, Gillian Marshman, H Miles Prince & John Sullivan. (2019) Psoriasis and cancer. An Australian/New Zealand narrative. Australasian Journal of Dermatology 60:1, pages 12-18.
Crossref
Crossref
Diederik De Cock & Kimme Hyrich. (2018) Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. Best Practice & Research Clinical Rheumatology 32:6, pages 869-886.
Crossref
Crossref
Marcin Marzejon, Monika Kosowska, Daria Majchrowicz, Barbara Bułło-Piontecka, Michał Wąsowicz & Małgorzata Jędrzejewska-Szczerska. (2018) Optical-Spectrometry-Based Method for Immunosuppressant Medicine Level Detection in Aqueous Solutions. Sensors 18:7, pages 2001.
Crossref
Crossref
Xuemei Zhao, Chengcai Xia, Xiaodan Wang, Hao Wang, Ming Xin, Long Yu & Yulong Liang. (2018) Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity. Frontiers in Pharmacology 9.
Crossref
Crossref
Y.M.F. Andersen, A. Egeberg, E. Balslev, C.L.T. Jørgensen, P.B. Szecsi, S. Stender, J. Kaae, A. Linneberg, G. Gislason, L. Skov, P.M. Elias & J.P. Thyssen. (2017) Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies. Journal of the European Academy of Dermatology and Venereology 31:6, pages 1038-1043.
Crossref
Crossref
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa & Angelo Viscido. (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 49:4, pages 338-358.
Crossref
Crossref
John Koo & Mio NakamuraJohn Koo & Mio Nakamura. 2017. Clinical Cases in Phototherapy. Clinical Cases in Phototherapy
123
127
.
M. Schmalzing, A. Strangfeld & H.-P. Tony. (2016) Medikamentöse Therapie der rheumatoiden Arthritis bei MalignomanamneseMedication treatment of rheumatoid arthritis with a history of malignancy. Zeitschrift für Rheumatologie 75:1, pages 22-31.
Crossref
Crossref
Youichi Ogawa, Tatsuyoshi Kawamura & Shinji Shimada. (2016) Squamous Cell Carcinoma in a Patient With Psoriasis After a 10-Year Administration of Cyclosporin A. Clinical Skin Cancer 1:1, pages 2-3.
Crossref
Crossref
Jennifer L. Herrmann & Siegrid S. Yu. (2015) Management of Merkel Cell Carcinoma. Current Dermatology Reports 4:4, pages 179-186.
Crossref
Crossref
Vito Annese, Laurent Beaugerie, Laurence Egan, Livia Biancone, Claus Bolling, Christian Brandts, Daan Dierickx, Reinhard Dummer, Gionata Fiorino, Jean Marc Gornet, Peter Higgins, Konstantinos H Katsanos, Loes Nissen, Gianluca Pellino, Gerhard Rogler, Franco Scaldaferri, Edyta Szymanska & Rami Eliakim. (2015) European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 9:11, pages 945-965.
Crossref
Crossref
Jiawei Shou, Jing Jing, Jiansheng Xie, Liangkun You, Zhao Jing, Junlin Yao, Weidong Han & Hongming Pan. (2015) Nuclear factor of activated T cells in cancer development and treatment. Cancer Letters 361:2, pages 174-184.
Crossref
Crossref
Qiongbo Hu & Tingyan Dong. 2015. Biocontrol of Lepidopteran Pests. Biocontrol of Lepidopteran Pests
169
206
.
David A. Khan. (2013) Alternative Agents in Refractory Chronic Urticaria: Evidence and Considerations on Their Selection and Use. The Journal of Allergy and Clinical Immunology: In Practice 1:5, pages 433-440.e1.
Crossref
Crossref
Timothy P. Wu, Kristen Miller, David E. Cohen & Jennifer A. Stein. (2013) Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin. Journal of the American Academy of Dermatology 69:3, pages 426-430.
Crossref
Crossref
Xinxin Tie, Sheng Han, Lingxuan Meng, Yunjie Wang & Anhua Wu. (2013) NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells. PLoS ONE 8:6, pages e66008.
Crossref
Crossref
M. D. Colombo, N. Cassano, G. Bellia & G. A. Vena. (2013) Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches. The Scientific World Journal 2013, pages 1-11.
Crossref
Crossref